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Pyrrolopyrimidine nucleosides analogs, collectively
referred to as deazapurines, are an important class
of structurally diverse compounds found in a wide
variety of biological niches. In this report, a cluster
of genes from Streptomyces rimosus (ATCC 14673)
involved in production of the deazapurine antibiotics
sangivamycin and toyocamycin was identified. The
cluster includes toyocamycin nitrile hydratase, an
enzyme that catalyzes the conversion of toyocamy-
cin to sangivamycin. In addition to this rare nitrile hy-
dratase, the cluster encodes a GTP cyclohydrolase I,
linking the biosynthesis of deazapurines to folate
biosynthesis, and a set of purine salvage/biosynthe-
sis genes, which presumably convert the guanine
moiety from GTP to the adenine-like deazapurine
base found in toyocamycin and sangivamycin. The
gene cluster presented here could potentially serve
as a model to allow identification of deazapurine bio-
synthetic pathways in other bacterial species.
INTRODUCTION
Pyrrolopyrimidine functional groups have been found in many
secondary metabolites produced by various strains of Strepto-
myces. The molecules in which they are found range from cofac-
tors involved in the biosynthesis of tetracycline antibiotics
(McCormick andMorton, 1982;Miller et al., 1960) andDNA repair
(Kuo et al., 1989) to compoundswith herbicidal, antibacterial, an-
tifungal, and antineoplastic activities (Isaac et al., 1991; Nishioka
et al., 1991; Suhadolnik, 1970). The breadth of structural diversity
in deazapurine-containing family of compounds is remarkable
(Figure 1A). The strong resemblance between pyrrolopyrimidine
nucleosides and purines suggest that these molecules could
disrupt nucleic acid metabolism and kinase-related signaling
cascades and be of potential use as therapeutic agents. The abil-
ity of deazapurines to enter nucleic acid pools of cells is well
documented (Ritch and Glazer, 1982; Suhadolnik et al., 1967,
1968; Tavitian et al., 1969; Uematsu and Suhadolnik, 1973). De-
spite the ubiquity and potential usefulness of these molecules790 Chemistry & Biology 15, 790–798, August 25, 2008 ª2008 Elsevboth as tools and therapies, their biosynthetic pathways have
remained elusive.
The outlines of the biosynthetic steps leading to these mole-
culeswere established by elegant radiotracer experiments (sum-
marized in Figure 1B) in which the deazapurine base was shown
to be derived from a purine precursor (Smulson and Suhadolnik,
1967; Suhadolnik and Uematsu, 1970; Uematsu and Suhadolnik,
1970) by way of a process mirroring transformations involved in
the formation of folate (Burg and Brown, 1966; Reynolds and
Brown, 1964) and riboflavin (Bacher and Maila¨nder, 1973).
When [2-14C]- or [8-14C]-labeled adenine and guanine were fed
to S. rimosus cells in culture, the isolated toyocamycin was
shown to have retained label at carbon-2 but lost the label at car-
bon-8. Intriguingly, the carbons 5 and 6 of the pyrrolemoiety, and
the cyano carbon appeared to derive from the C10, C20, and C30
of the proffered ribose, respectively.
Though the exact nature of the enzymatic transformations that
underlie the biosynthesis of deazapurines remains to be estab-
lished, two studies have provided substantial hints. First, Suha-
dolnik and coworkers isolated a GTP cyclohydrolase protein
from cells producing sangivamycin, whose activity paralleled
the appearance of sangivamycin in the growth medium (Elstner
and Suhadolnik, 1971, 1975); the protein was shown to produce
a neopterin-likemolecule, much like the product of GTP cyclohy-
drolase I (GCH I) of E. coli, which had been characterized by
Brown and colleagues (Burg and Brown, 1968). The pyrimidine
ring of sangivamycin or toyocamycin, however, resembles ade-
nine and not guanine, suggesting that additional transformations
must be involved, if the protein described in these early studies
indeed catalyzes the first step in the biosynthesis of these dea-
zapurines. The second intriguing observation was the descrip-
tion of a toyocamycin nitrile hydratase (TNHase) activity involving
addition of a water molecule across the nitrile moiety of toyoca-
mycin to produce sangivamycin (Uematsu and Suhadolnik,
1974, 1975; Figure 1B).
The hypermodified tRNA base queuosine (Kasai et al., 1975) is
structurally homologous to the deazapurine base of pyrrolopy-
rimidine nucleosides that are produced by Streptomyces. Re-
cently, four genes (queC, queD, queE, and queF) encoding
proteins required for the biosynthesis of queuosine have been
identified in Bacillus subtillis (Bai et al., 2000; Van Lanen et al.,
2005). The importance of the four B. subtillis genes in the early
steps was verified by gene knockout experiments. Though bioin-
formatics studies have revealed the potential biochemicalier Ltd All rights reserved
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been carried out for QueF, which has been shown to catalyze
the NADPH-dependent conversion of 7-cyano-7-deazaguanine
(see preQ0 in Figure 2B) to 7-aminomethyl-7-deazaguanine
(preQ1) (Lee et al., 2007; Van Lanen et al., 2005). However, the
reaction(s) catalyzed for the remaining three have yet to be es-
tablished. Recent X-ray crystallographic studies of QueC (Cicmil
and Huang, 2008), QueD (Cicmil and Shi, 2008), and QueF
(Swairjo et al., 2005) may provide additional insights into their
biochemical function.
Streptomyces tend to organize genes that are responsible for
the biosynthesis of secondary metabolites in distinct clusters
(Hopwood, 1997); therefore, identification of a cluster of genes
involved biosynthesis of any deazapurine secondary metabolite
produced by Streptomyces could potentially inform on the bio-
synthetic pathway for these compounds. Because the genome
sequence of S. rimosus is not available, identification of the
genes responsible for biosynthesis of these secondary metabo-
lites required a different approach. In this work we utilized
forward genetics methods to identify the gene for TNHase in
S. rimosus. Additional biochemical and bioinformatics analysis
leave little doubt that this cluster is indeed the elusive deazapur-
ine secondary metabolite biosynthesis cluster.
Figure 1. Deazapurines Are a Diverse Class of Purine-Based
Secondary Metabolites
(A) Deazapurine secondary metabolites produced by Streptomyces.
(B) Deazapurine secondary metabolites are derived from purines in a pathway
that retains C-2, as well as C-10, C-20, and C-30 of the starting purine, but loses
the C-8. Toyocamycin nitrile hydratase catalyzes the hydration of toyocamycin
to produce sangivamycin. S. rimosus produces both sangivamycin and
toyocamycin.Chemistry & Biology 15, 7RESULTS
We undertook a forward genetic approach to isolate a cluster of
genes that is responsible for the biosynthesis of deazapurines in
Streptomyces, which are known to produce a large variety of
deazapurine-containing secondary metabolites in the stationary
phase of growth (Suhadolnik, 1970). S. rimosus (ATCC strain
14673) was chosen as the model organism in this study because
it is known to produce two compounds: sangivamycin and
toyocamycin (Elstner and Suhadolnik, 1971; Suhadolnik, 1970;
Suhadolnik and Uematsu, 1970; Uematsu and Suhadolnik,
1970, 1974). Furthermore, Suhadolnik and colleagues had iden-
tified a TNHase in this organism (Uematsu and Suhadolnik, 1974,
1975); we reasoned that TNHase would be a goodmarker for the
location of the biosynthetic cluster asStreptomyces tend to clus-
ter the genes for the biosynthesis of secondary metabolites
(Hopwood, 1997).
Isolation of the TNHase-Bearing Cluster
from S. rimosus (ATCC 14673)
TNHase was partially purified from a 3-day-old culture growth
by a combination of ammonium sulfate precipitation and seven
chromatographic steps, which included anion exchange, hy-
drophobic interactions, and hydroxyapatite and size exclusion
chromatography. At each step of the purification, the TNHase
activity present in the fractions was monitored by an HPLC as-
say, which followed the conversion of toyocamycin to sangiva-
mycin. Though SDS-PAGE of the resulting partially purified
Figure 2. Identification of Toyocamycin Nitrile Hydratase of
S. rimosus
SDS-PAGE analysis of proteins contained in consecutive fractions eluting from
a HiPrep 16/60 Sephacryl S-200 analytical size exclusion column during
purification of toyocamycin nitrile hydratase activity from S. rimosus (A). The
intensities of protein bands 1, 2, and 3 correlate with TNHase activity over
the range of fractions shown (Figure S1). N-terminal sequences of bands 1,
2, and 3 (B) were obtained by Edman degradation. TNHase is a three-subunit
nitrile hydratase protein (C) with sequence similarity to nitrile and thiocyanate
hydratase proteins. Each of these proteins has a metal ion in the active site
(cobalt or iron), which interacts with two posttranslationally modified cysteine
residues (shown in red).90–798, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 791
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plex mixture, the intensities of three bands appeared to corre-
late with the magnitude of the toyocamycin/sangivamycin
activity that was observed in each fraction (see Figure S1 avail-
able online). Therefore, we reasoned that these proteins were
likely to comprise the TNHase protein that we had sought to
purify.
The N-terminal amino acid sequences (R30 amino acids) of
each of the three bands were obtained by Edman degradation
(Figure 2B). The 40-amino acid read obtained from the N termi-
nus of band 3 permitted degenerate primers corresponding to
N- and C-terminal portions of the sequence to be designed
and used to amplify by PCR a 78 bp region from the S. rimo-
sus genomic DNA. Cloning and sequencing of the PCR prod-
uct revealed the genomic sequence encoding the amino acids
9–34 of band 3. A synthetic DNA oligomer containing this
78 bp sequence was used to probe a cosmid library of
S. rimosus for the corresponding gene. Cosmids that hybrid-
ized to the probe were isolated, digested into smaller frag-
ments by various restriction endonucleases, and subcloned.
Sequencing of the subcloned DNA fragments revealed over-
lapping sequences, which were assembled into a 14.5 kbp
stretch of DNA that contains the toyocamycin and sangiva-
mycin biosynthesis cluster of S. rimosus, including three
subunits that encode toyocamycin nitrile hydratase observed
in the purification.
The open reading frames that encode the deazapurine biosyn-
thesis cluster in this organism were identified and annotated
manually (Figure 3A) . Potential ORFswere identified by the pres-
Figure 3. Toyocamycin and Sangivamycin
Are Produced by a Cluster of Genes in S. ri-
mosus
Organization of gene cluster (A) and putative bio-
synthetic pathway for production of sangivamycin
and toyocamycin (B). Radiotracer experiments
(Suhadolnik and Uematsu, 1970) have shown
that during the conversion of purines to toyocamy-
cin, carbon 2 (orange) is retained and carbon 8
(blue) is lost and that the pyrrole carbons in toyo-
camycin (red) are derived from the ribose on the
nucleoside precursor (Uematsu and Suhadolnik,
1970.) Predicted functions of gene products are
based on hits in PSI-BLAST analysis. The putative
functions of the proteins are as follows: toyA, LuxR
transcriptional regulator; toyB, 6-pyruvoyltetrahy-
dropterin synthase; toyC, radical SAM family pro-
tein; toyE, GMP reductase; toyF, adenylosucci-
nate lyase; toyG, adenylosuccinate synthetase;
toyH, phosphoribosylpyrophosphate transferase;
toyI, phosphatase; toyK, QueC-related protein.
Functions of ToyD (GTP cyclohydrolase I) and
ToyJKL (toyocamycin nitrile hydratase) were dem-
onstrated biochemically in this study.
ence of potential start codons, ATG,
GTG, and TTG, preceded by reasonable
ribosome binding sites (containing a se-
ries of adenosine and guanosine bases),
and in-frame stop codons. The putative
functions of each orf were gleaned from
analyzing the results of PSI-BLAST (Altschul et al., 1997)
searches of the sequences against bacterial protein databases.
Pyrrolopyrimidine Nucleoside Antibiotic Biosynthesis
Gene Cluster of S. rimosus
Sequence analysis revealed at least 13 putative ORFs clustered
together, including the TNHase gene (Figure 3A). The ORFs that
comprise the gene cluster are designated toyABCDEFGHIJKLM;
the ORFs encoding protein bands 1, 2, and 3 of the TNHase
protein isolated from S. rimosus are designated toyJ, L, and K,
respectively. The ORFs in this cluster are listed in Table 1.
In addition to the TNHase genes, this group also includes
a GCH I homolog, which has long been suspected to be one of
the key enzymes required for the biosynthesis of deazapurines
in Streptomyces. This result is completely in accord with the
work of Suhadolnik and coworkers showing appearance of
GCH I in cells during production of sangivamycin (Elstner and
Suhadolnik, 1971, 1975). The cluster also includes genes encod-
ing a putative 6-pyruvoyltetrahydropterin synthase (PTPS), a
member of the radical SAM protein family (Sofia et al., 2001)
and a member of the ExsB protein family; similar proteins
(QueD, QueE, and QueC, respectively) have previously been
shown to be involved in queuosine biosynthesis (Gaur and
Varshney, 2005; Reader et al., 2004). Most importantly, however,
our data show how the organism converts a guanine-based
purine to an adenine-based deazapurine. This task appears to
be accomplished by a group of purine salvage/biosynthesis pro-
teins (phosphoribosylpyrophosphate transferase, GMP reduc-
tase, and adenylosuccinate synthetase and lyase homologs).792 Chemistry & Biology 15, 790–798, August 25, 2008 ª2008 Elsevier Ltd All rights reserved
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ORF Ribosome Binding Site Start (stop) % (G + C) MW (residues) Predicted/Known Function
toyA AAAGA ATG (TGA) 74.5 101,436 (961) LuxR transcriptional regulator
toyB GGGGAA TTG (TGA) 65.4 15,114 (131) Pyruvoyl-tetrahydropterin synthase
toyC GGGAAGGGG GTG (TGA) 71.1 26,743 (243) Radical SAM
toyD AGGAGAG ATG (TGA) 71.2 22,140 (200) GCH I (verified, this study)
toyE AGAGAAAGAA GTG (TGA) 74.0 39,492 (384) GMP reductase
toyF GGAGG GTG (TGA) 72.6 49,005 (452) Adenylosuccinate lyase
toyG AAGGAGGA ATG (TGA) 73.7 36,855 (351) Adenylosuccinate synthetase
toyH AAGGAG ATG (TGA) 73.3 18,859 (176) Phosphoribosyl-pyrophosphate transferase
toyI GGAGG GTG (TGA) 75.3 25,466 (241) Haloacid dehalogenase superfamily
toyJ GGAGGAGAAA ATG (TGA) 71.8 21,215 (195) Nitrile hydratase, a subunit (verified, this study)
toyK AGAAGGGGA GTG (TGA) 71.2 10,105 (91) Nitrile hydratase, g subunit (verified, this study)
toyL GGGAAA ATG (TGA) 66.3 11,543 (103) Nitrile hydratase, b subunit (verified, this study)
toyM AGGAGG TTG (TGA) 69.2 25,583 (238) ExsB familyActivity of Heterologously ExpressedS. rimosus TNHase
To confirm that the toyJKL genes indeed encode the TNHase
protein, which was the basis for the isolation of the gene cluster,
these genes were cloned into vectors with compatible origins of
replication and transformed into E. coli BL21(DE3) cells. Cell ly-
sates of E. coli containing exogenously expressed TNHase sub-
units ToyJ, K, and L were incubated with toyocamycin and ana-
lyzed by HPLC. Control incubations of cell lysate from E. coli
transformed with the corresponding expression vectors alone
were performed as well. The HPLC analysis revealed conversion
of toyocamycin to sangivamycin by cell lysate from cells contain-
ing expression constructs for ToyJ, K, and L (Figure 4). By con-
trast, TNHase activity was not observed in lysates of vector only
controls. Moreover, in preliminary studies, purified TNHase
(ToyJKL) exhibits the toyocamycin/sangivamycin activity
(data not shown).
The three-subunit TNHase protein isolated in the course of
these studies is unique in a number of respects. First, it catalyzes
hydration of a cyanide moiety appended to a complex organic
molecule, substantially expanding the repertoire of substrates
for hydration, and may represent a mild alternative to chemical
hydration of cyanide-containing compounds to nitriles. Second,
TNHase contains three subunits, whereas other nitrile hydratase
(NHase) enzymes studied to date contain only two (Kobayashi
et al., 1992; see Figure 2C). BLAST sequence analysis reveals
that ToyJ is similar to the a subunits found in other NHase
enzymes. However, ToyL and ToyK show identity with the N-
and C-terminal halves, respectively, of the b subunit of NHase
enzymes. Curiously, thiocyanate hydrolase (SCNase) from Thio-
bacillus thioparus THI115, which catalyzes the conversion of
thiocyante to carbonyl sulfide and ammonia, contains three sub-
units (Katayama et al., 1992), which are homologous to those that
compriseS. rimosusTNHase. Theaandb subunits ofT. thioparus
SCNase share similaritieswith theN- andC-terminal halves of the
b subunit of typical NHase enzymes (Katayama et al., 1998); the g
subunit of thiocyanate hydrolase is homologous to the a subunit
of NHase and TNHase (see Figure 2C).
The rarity of NHase enzymes is a consequence not only of the
fact that they catalyze hydration of an uncommon biological moi-
ety, an alkyl cyanide, but they do so using either a mononuclearChemistry & Biology 15, 7nonheme iron or noncorrinoid cobalt (Banerjee et al., 2002). The
metal ion is bound to the active site in an unusual mononuclear
six-coordinatemetal site, and sequence analysis reveals a signa-
ture amino acid sequence Val-Cys1-Ser/Thr-Leu-Cys2-Ser-Cys3
in the a subunit; in all cases examined to date, two of the three
Cys residues (Cys2 and Cys3) are modified to cysteine sulfinic
acid (Cys2-SO2H) and cysteine sulfenic acid (Cys3-SOH), re-
spectively (Arakawa et al., 2007; Nagashima et al., 1998; Song
et al., 2007). Iron or cobalt preference of the proteins is thought
to be dictated as follows: proteins that have a Ser residue
between Cys1 and Cys2 bind iron, where as the presence of
Thr directs binding of cobalt (Banerjee et al., 2002; Payne
et al., 1997). ToyJ encodes the amino acid sequence V-C-T-
L-C-S-C; therefore, we presume that it is a cobalt-type nitrile
hydratase. Additional studies on this fascinating protein are
currently in progress.
Activity of Heterologously Expressed
GCH I Homolog from S. rimosus
To determine if toyD encodes a GCH I homolog that catalyzes
the canonical reaction, the gene was cloned, ToyD was overex-
pressed, purified, and assayed for its GCH I activity. GCH I is
a zinc-containing protein (Auerbach et al., 2000; Kaiser et al.,
2002) and catalyzes the conversion of GTP to 7,8-dihydroneop-
terin triphosphate (H2NTP). Recombinant purified S. rimosus
ToyD was shown to bind 0.76 M of zinc per mole of monomer.
The conversion of GTP to 7,8-dihydroneopterin triphosphate
(H2NTP) is readily monitored by UV-visible spectrophotometry.
Changes in the spectral properties of GTP upon incubation with
ToyD are shown in Figure 5A. Incubation with ToyD leads to a de-
crease in absorbance at 253 nm due to GTP, with a concomitant
increase at 330 nm,which is consistentwith conversion ofGTP to
H2NTP (Pfleiderer, 1985). The turnover number for this reaction
was determined to be 0.4 min1 (at pH 8.0). Though low, this
value is consistent with the relatively low (0.2–2.5min1) turnover
numbers that have been observed with GCH I proteins studied to
date (Bracher et al., 1999; El Yacoubi et al., 2006; Rebelo et al.,
2003). The formation ofH2NTPwas confirmedby LC/MSanalysis
of the reaction (Figure 5B). In these experiments, we compared
the mass and retention time for the product produced by ToyD90–798, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 793
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conditions of the assays and analysis, H2NTP is oxidized to neo-
pterin triphosphate, as has been observed in the past (El Yacoubi
et al., 2006). Extracted ion chromatograms of theGCH I reactions
(in the negative ion mode) reveal a peak with product withm/z of
492 amu (Figure 5B), which elutes at an identical position as the
product of ToyD. Furthermore, when equal quantities of the E.
coli GCH I and S. rimosus ToyD reaction mixtures are combined
and injected, a single peak is observed. Finally, when enzyme is
excluded, the H2NTP is not observed. Collectively, these results
confirm that ToyD is indeed a GCH I homolog. Additional control
experiments demonstrated that, as with GCH I, ToyD does not
catalyze cyclohydrolase chemistry with GDP, GMP, ATP, ADP,
or AMP (data not shown). To confirm that the GCH I activity ob-
served in purified recombinant ToyD, exogenously expressed in
E. coli, is not due to contaminating E. coli FolE, samples of the
two purified proteins used in this study (ToyD and FolE) were
analyzed by SDS-PAGE. Because FolE has a calculatedmolecu-
lar weight 2.7 kDa greater than ToyD, the two are resolved by
SDS-PAGE to reveal that the ToyD used in these experiments is
not contaminated by E. coli FolE (Figure S2).
Whether ToyD is the same protein that Suhadolnik and
coworkers purified from the organism in 1975 (Elstner and Suha-
Figure 4. ToyJKL Encode Toyocamycin Nitrile Hydratase
Trace (A) is a standard mixture of sangivamycin and toyocamycin. The activity
was assayed in crude extracts from E. coli strains that contained either the
toyJKL genes (C) or the corresponding empty vectors (pACYCDuet-1 and
pET29a) (B).794 Chemistry & Biology 15, 790–798, August 25, 2008 ª2008 Elsevdolnik, 1975) cannot be known for certain, as S. rimosus may
encode multiple open reading frames that catalyze similar or
identical reactions, as we have shown in the past for GTP cyclo-
hydrolase II in S. coelicolor (Spoonamore and Bandarian, 2008;
Spoonamore et al., 2006). Therefore, at present, we cannot rule
out the presence of additional homologs of GCH I in S. rimosus.
DISCUSSION
We have identified the gene encoding the toyocamycin nitrile hy-
dratase enzyme in S. rimosus and have sequenced a series of
adjacent putative ORFs comprising what appears to be a cluster
of genes for the biosynthesis of the pyrrolopyrimidine nucleo-
sides sangivamycin and toyocamycin. A pathway for conversion
of GTP to sangivamycin or toyocamycin is depicted in Figure 2B.
The biosynthesis is proposed to occur in three phases: in the first
phase, the starting purine nucleotide is tailored to the deazapur-
ine base, the second phase involves conversion of the guanine-
like base to an adenine-like base, and modifications in the 7-
position occur in the third phase.
Our working model is that first phase in the biosynthesis of
toyocamycin is achieved through four steps catalyzed by
ToyD, ToyB, ToyC, and ToyM. According to this scheme, ToyD
catalyzes the conversion of GTP to H2NTP; in this article we
show that ToyD has the expected enzymatic activity. Though
the involvement of a GCH I protein in deazapurine biosynthesis
has been hypothesized previously (Elstner and Suhadolnik,
1975; Reader et al., 2004), this report is the first demonstration
that a GCH I protein with canonical activity is colocalized with
the genes for the biosynthesis of a deazapurine. The additional
steps involved in the transformation of H2NTP to the deazapurine
preQ0 occur through the action of the ToyB, ToyC, and ToyM trio.
The nature of the chemistry and order in which these enzymes
act remain to be established. However, homologs of ToyB,
ToyC, and ToyM are involved in the biosynthesis of preQ0, which
is a precursor the hypermodified base queuosine (Reader et al.,
2004). The chemical transformations catalyzed by each of the
three remain to be established; however, the presence of the
same three genes in the toyocamycin biosynthesis pathway
provides a universal paradigm for the biosynthesis of deazapur-
ine-containing compounds in nature. The origin of the cyano
nitrogen is not known. Though the most parsimonious path is
one where it is derived fromN-7 of the starting purine, we cannot
exclude the possibility that it is eliminated and the cyano nitrogen
is derived from another source.
We note in passing that the gene encoding the radical SAM
homolog in the toyocamycin biosynthesis pathway encodes
a TGA stop codon 30 bp from the GTG, which we have assigned
as the start codon for the gene. Read-through of TGA stop
codons, generally by insertion of a selenocysteine, is rare, but
precedented. To our knowledge, Streptomyces species have
not been shown to produce selenoproteins; moreover, the com-
pleted genome sequences of S. avermitilis and S. coelicolor lack
genes encoding selenocysteyl tRNA, or other homologs of the
bacterial selenocysteine incorporation systems. At this point,
one cannot rule out that the selenocysteine incorporation
pathways have diverged. Although PSI-BLAST searches reveal
few examples of homologs that have similarity over the first
11 amino acids of ToyC, significant similarity, including in theier Ltd All rights reserved
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between the in-frame TGA and the next potential start codon.
In the second phase of the biosynthetic pathway, we propose
that the preQ0 base is converted to the toyocamycin 5
0-mono-
phosphate by the successive action of ToyH, ToyE, ToyG, and
ToyF as shown in Figure 3B. The functional assignments are
based on sequence similarities. Intriguingly, these enzymes
may have been ‘‘borrowed’’ from those involved in purine sal-
vage/biosynthesis; it would be interesting to know if intragenomic
homologs of these proteins, which carry out housekeeping func-
tions, are present elsewhere in the chromosome. In this phase of
the pathway, the only ORFwhose functional assignment is ques-
tionable is ToyI. The toyI gene encodes a protein that is homolo-
gous to the HAD superfamily of enzymes, which includes a large
Figure 5. ToyD Is a GTP Cyclohydrolase I
UV spectrophotometric assays showing conver-
sion of GTP to H2NTP by S. rimosus ToyD (A)
were carried out as described in Experimental
Procedures. The identity of the product was con-
firmed by LC-MS analysis of the reaction and
comparison to that observed with E. coli GCH I
(FolE). (B) Extracted negative ion chromatograms
of the GCH I product (at 492 amu for neopterin
triphosphate) show peaks with identical retention
times for the product of E. coli FolE and S. rimosus
toyD. Identity of the product was confirmed by
coinjection of a sample containing equal volumes
of E. coli FolE and S. rimosus ToyD reaction mix-
tures. The product is not observed when the
enzyme is omitted. 7,8-Dihydroneopterin triphos-
phate, which is the initial product of both reac-
tions, is oxidized to neopterin triphosphate in the
course of the analysis.
family of phosphatases (Burroughs et al.,
2006); we posit that ToyI could be in-
volved in dephosphorylation of toyoca-
mycin monophosphate, setting the stage
for the third and final phase of the biosyn-
thetic pathway.
The third phase of the pathway involves
addition of water across the nitrile moiety
of toyocamycin to yield sangivamycin.
ToyJKL belongs to a rare metal-depen-
dent nitrile hydratase family of proteins.
Heterologousexpression of theS. rimosus
TNHaseenzyme inE.coliand theobserva-
tion of TNHase activity in the lysate from
these cells establishes a solid connection
between the S. rimosus protein bands for
which N-terminal sequences were ob-
tained and TNHase activity. Assays with
the purified ToyJKL confirm this observa-
tion (data not shown); studies on the
mechanisms of the reaction(s) catalyzed
by this protein are currently underway.
The pathway shown in Figure 2B is not
the only possible one that could have
been proposed based on the available genes. For instance,
one may imagine that the cyano group of preQ0 could be hy-
drated first, prior to being appended to a ribose moiety. Access
to the entire set of recombinant proteins encoded by the Toy
cluster permits these questions to be addressed, and the chem-
ical transformations that underlie conversion of purines to dea-
zapurines to be unraveled.
SIGNIFICANCE
Deazapurine-containing compounds are widespread in
nature. They are used in biological niches as diverse as the
hypermodified tRNA base queuosine, which is found in
nearly all organisms, to secondary metabolites that areChemistry & Biology 15, 790–798, August 25, 2008 ª2008 Elsevier Ltd All rights reserved 795
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containing secondary metabolites, such as sangivamycin,
and their chemically modified derivatives are of importance
clinically as they have long been known to partition into
nucleic acid pools and have demonstrated antineoplastic,
antiviral, and antimicrobial activity. Current research efforts
aimed at examining the therapeutic potential of natural and
derivatized deazapurines, as well as development of novel
deazapurine synthetic routes, are active subjects of investi-
gation. Though early radiotracer work has suggested that
the biosynthetic routes toward diverse deazapurines pro-
ceed by way of similar steps, the absence of a complete
set of deazapurine biosynthetic genes has made the exact
chemical transformations difficult to decipher. The cluster
presented here represents the first apparently complete
set of genes required for the biosynthesis of a deazapurine
secondary metabolite and is of significance for a number
of reasons. First, the data clearly show a biosynthetic link
between production of queuosine and formation of deaza-
purine-based secondary metabolites produced by Strepto-
myces. Second, access to the proteins involved in the
biosynthesis of deazapurines could lead to development of
semisynthetic paths toward known or novel deazapurines.
Third, the gene cluster presented in this work will aid identi-
fication of deazapurines and deazapurine biosynthetic
clusters that have yet to be discovered.
EXPERIMENTAL PROCEDURES
Isolation of the Sangivamycin/Toyocamycin Biosynthesis Cluster
Partial purification of TNHase, N-terminal sequencing, preparation and
screening of the cosmid library, and annotation of the cluster are described
in Supplemental Data.
Cloning, Expression, and Purification of Recombinant
S. rimosus GCH I (ToyD)
The toyDORFwas amplified fromS. rimosus genomicDNAbyPCR, subcloned
into pGEM-T easy vector and finally into theHindIII- andNdeI-digested pET29a
for expression of native recombinant protein. Constructs were introduced by
electroporation into E. coli BL21(DE3) for protein expression. One colony
from transformants containing the expression plasmid, grown at 37C on LB
media containing 34 mg/ml kanamycin, was used to inoculate 0.05 liter LB
starter culture containing 34 mg/ml kanamycin. The overnight starter culture
was used to inoculate four single liters of LB media containing 34 mg/ml kana-
mycin. Cells were grown at 18C to an OD600nm 1, at which point ZnSO4 was
added (0.1 mM final) and protein expression was induced by adding IPTG (0.1
mM). Cells were harvested after 16 hr by centrifugation (20,5003 g). All subse-
quent steps were carried out at 4C. Cells were suspended in 20 mM Tris-SO4
(pH 8.0) containing 5mMdithiothreitol (buffer A) and 1mMPMSF and lysed us-
ing a Branson 450D sonifier at 60% power. The cell lysate was centrifuged at
26,500 3 g for 30 min. The soluble extract was loaded on a Q-Sepharose col-
umn (2.63 12.5 cm), which had been pre-equilibrated in buffer A. The column
wasdevelopedwith a linear gradient inbufferA first to 0.15MNaCl over 0.1 liter,
then washed with buffer A containing 0.15 M NaCl. Fractions containing ToyD
(as judged by SDS-PAGE) were pooled, taken to 1M ammonium sulfate by ad-
ditionof an equal volumeof a solution of buffer A containing 2Mammoniumsul-
fate, and loaded on a butyl-Sepharose column (2.63 12.5 cm) in buffer A con-
taining 1 M ammonium sulfate. A 0.7 liter linear gradient in buffer A from 1 M
ammonium sulfate to buffer A containing 30% ethylene glycol was applied.
Fractions containing ToyD (as judged bySDS-PAGE)were pooled and dialyzed
against 2 liters of bufferAwithonebuffer change. Theproteinwasconcentrated
in an Amicon pressure cell (YM-10 membrane). Protein was quantified with
a BCA assay, and metal content was determined by ICP-OES by Garratt-Call-
ahan Company.796 Chemistry & Biology 15, 790–798, August 25, 2008 ª2008 ElsevActivity Assays for S. rimosus ToyD and E. coli FolE
UV spectrophotometric assays used to determine kcat for ToyD GCH I activity
were carried out in the presence of 0.1 M Tris-HCl (pH 8.0), 0.1 M KCl, and
0.2 mMGTP. The UV spectra presented in Figure 5 were obtained from a reac-
tionmixturecontaining20mMTris-HCl (pH8.0), 1mMdithiothreitol, and0.1mM
GTP; spectra shown were obtained at 5 min intervals. UV-visible spectra
were recorded on an Agilent 8453 spectrophotometer after addition of 10 mM
protein. The rate of conversion of GTP to H2NTP was monitored by observing
changes in absorbance at 330 nm (3 = 6,300M1 cm1). GCH I assays for anal-
ysis by LC-MS were carried out in the presence of 0.02 M Tris-SO4 (pH 8.0),
2mMdithiothreitol, 0.1MKCl, and100mMGTP.Reactionswere allowed topro-
ceed for 120 min at ambient temperature and quenched by centrifugation for
5min at 14,0003 g throughNanosep (10 KMWCO)Omega centrifugal devices
(Pall Life Sciences) to remove enzymeprior to being analyzed by reverse-phase
HPLC. An aliquot (20 ml) of each reactionmix was injected onto a 1003 4.6mm
5mmHypercarb column (Thermo Scientific) which had been pre-equilibrated in
a buffer containing 95% 50 mM ammonium acetate, 0.1% diethylamine, and
5% acetonitrile at a flow rate of 0.5 ml/min. The column was developed with
a linear gradient from 5% to 18% ACN between 2 and 14 min followed by an
increase from 18% to 95% ACN between 17 and 27 min. UV-visible spectra
were obtained from 220 to 500 nm using a ThermoFinnigan Surveyor photodi-
ode array detector. Mass spectra were obtained in negative ion mode, scan-
ning the mass-to-charge ratio range of 300–550 amu using ES ionization-
equipped LCQ ThermoFinnigan Deca XP mass spectrometer. The instrument
was set at 42 V ionization energy and 300C ion source temperature.
Cloning and Assays of S. rimosus TNHase
Genes for the three subunits of TNHase (toyJ, toyK, and toyL) were amplified
from S. rimosus genomic DNA by PCR. DNA encoding toyJ and toyK were
cloned between NdeI/XhoI and NcoI/HindIII sites of pACYC DUET-1, respec-
tively, for simultaneous expression of both proteins. DNA encoding toyL was
cloned between NdeI and HindIII sites in pET29 vector. For the assays,
pACYCDuet-1 containing toyJ and toyK and pET29 containing toyL were
electroporated into E. coli BL21(DE3). Control strains containing the empty
pACYCDuet-1 and pET29 vectors were also prepared. Transformants were
plated on LB agarose plates. In this and all subsequent fermentations, 34 mg/ml
each of kanamycin and chloramphenicol were included. A single colony was
used to inoculate a 1ml overnight culture containing the appropriate antibiotic.
The overnight culture was added to a flask containing 0.05 liter of LB with the
appropriate antibiotic(s) and grown to OD600nm 0.5; protein expression was
induced by addition of IPTG to a final concentration of 0.1 mM. Because we
suspected that TNHasewas a cobalt-dependent protein (see text), the cultures
were also supplemented with 0.1 mM CoCl2. After 4 hr, 1 ml of the culture was
removed, and cells were pelleted and suspended in 50 mM KPi (pH 7.4). Cells
were lysed by sonication and clear lysateswere obtained by centrifugation. To-
tal protein concentration in the cleared lysatewas determined by aBCAprotein
assay. A volume of cell lysate containing 5 mg total protein was combined with
a 0.1 ml solution containing 0.05 M KPi (pH 7.4) and 0.1 mM toyocamycin. The
samples were incubated 15 min at room temperature, and the enzyme was
removed using a Microcon YM-10 centrifugal filtration device. An aliquot of
the flowthrough (10 mL) was analyzed by HPLC over a Zorbax Eclipse C-18
column (4.63 250mm). Baseline separation of sangivamycin and toyocamycin
wasachievedby isocraticelutionwithamixtureof 85%0.1Mtriethylammonium
acetate (pH 6.8) and 15%methanol. Under these conditions, sangivamycin and
toyocamycin elute at 15.2 and 19.7 min, respectively.
ACCESSION NUMBERS
The cluster of genes described in this article was deposited at the National
Center for Biotechnology Information (NCBI) under accession number
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